CATALOGO DEI PRODOTTI DELLA RICERCA

BELLUOMINI, Lorenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.978
EU - Europa 1.972
AS - Asia 1.874
SA - Sud America 322
AF - Africa 85
OC - Oceania 14
Totale 6.245
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.898
SG - Singapore 837
RU - Federazione Russa 685
CN - Cina 366
IT - Italia 340
HK - Hong Kong 269
BR - Brasile 264
DE - Germania 244
FI - Finlandia 130
FR - Francia 104
GB - Regno Unito 93
SE - Svezia 90
VN - Vietnam 90
KR - Corea 88
IE - Irlanda 73
PL - Polonia 60
NL - Olanda 57
CA - Canada 51
IN - India 40
ID - Indonesia 37
JP - Giappone 35
TG - Togo 27
BJ - Benin 25
ES - Italia 22
AT - Austria 20
TR - Turchia 20
MX - Messico 19
AR - Argentina 15
CZ - Repubblica Ceca 15
AU - Australia 11
BD - Bangladesh 11
EC - Ecuador 11
IR - Iran 10
CO - Colombia 9
VE - Venezuela 9
MA - Marocco 8
ZA - Sudafrica 8
BE - Belgio 7
LT - Lituania 7
MY - Malesia 7
PK - Pakistan 7
AZ - Azerbaigian 6
JO - Giordania 6
TW - Taiwan 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
UZ - Uzbekistan 5
EG - Egitto 4
IQ - Iraq 4
KE - Kenya 4
UA - Ucraina 4
UY - Uruguay 4
AO - Angola 3
CH - Svizzera 3
DK - Danimarca 3
IL - Israele 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
HN - Honduras 2
KH - Cambogia 2
KZ - Kazakistan 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PT - Portogallo 2
SA - Arabia Saudita 2
SV - El Salvador 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GD - Grenada 1
GT - Guatemala 1
JM - Giamaica 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MG - Madagascar 1
MK - Macedonia 1
MU - Mauritius 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
RO - Romania 1
RS - Serbia 1
SD - Sudan 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
WS - Samoa 1
Totale 6.245
Salva come PNG Salva come JPEG
Città #
Dallas 536
Singapore 352
Hong Kong 259
Ashburn 217
Moscow 172
Chandler 155
Munich 154
Los Angeles 75
Helsinki 74
Beijing 72
Dublin 72
Verona 70
New York 52
Milan 45
The Dalles 45
London 40
Meda 38
São Paulo 38
Redondo Beach 36
Ho Chi Minh City 35
Tokyo 32
Buffalo 31
Turku 28
Lomé 27
Cotonou 25
Nuremberg 23
Jakarta 22
Warsaw 22
Redmond 21
Santa Clara 21
Lawrence 20
Princeton 20
Rome 19
Amsterdam 18
Columbus 18
Sindelfingen 18
Hanoi 17
Lappeenranta 17
Seoul 17
Chicago 16
Toronto 16
Atlanta 14
Brooklyn 14
Houston 14
Montreal 14
Frankfurt am Main 13
San Francisco 13
Seattle 13
Council Bluffs 12
Denver 12
Washington 12
Boardman 11
Boston 11
Belo Horizonte 10
Brno 10
Chennai 10
Falkenstein 10
Phoenix 10
Stockholm 10
Wilmington 10
Orem 9
Vicenza 9
Vienna 9
Haiphong 8
Ottawa 8
Rio de Janeiro 8
Trento 8
Brussels 7
Bursa 7
Chapel Hill 7
Jacksonville 7
Johannesburg 7
Mumbai 7
Padova 7
Porto Alegre 7
Sydney 7
Tianjin 7
Amman 6
Baku 6
Bengaluru 6
Dongguan 6
Jinan 6
Jyväskylä 6
Kent 6
Naples 6
Poplar 6
Querétaro 6
Shenyang 6
Turin 6
Charlotte 5
Curitiba 5
Hangzhou 5
Isola della Scala 5
Krakow 5
Menlo Park 5
New Delhi 5
Salvador 5
Shanghai 5
Tashkent 5
Zhengzhou 5
Totale 3.464
Salva come PNG Salva come JPEG
Nome #
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 249
Exploring the Complex Interplay between Myeloid-Derived Suppressor Cells (MDSCs), Interleukins, and Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC) 248
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic 138
A multimodal approach to cancer-related cachexia: from theory to practice 135
Abscopal effect and resistance reversion in nivolumab-treated non-small-cell lung cancer undergoing palliative radiotherapy: a case report 129
Exercise prehabilitation in lung cancer: Getting stronger to recover faster 128
A Feasibility Study Investigating an Exercise Program in Metastatic Cancer Based on the Patient-Preferred Delivery Mode 127
Integrating supportive care into the multidisciplinary management of lung cancer: we can't wait any longer 123
A cross-sectional study evaluating the exercise discussion with oncologist during cancer consultation: the CONNECT study 121
Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone Unturned 119
How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center 118
A narrative review on tumor microenvironment in oligometastatic and oligoprogressive non-small cell lung cancer: a lot remains to be done 117
Maintenance or consolidation therapy in small-cell lung cancer: an updated systematic review and meta-analysis 116
Infections and Immunotherapy in Lung Cancer: A Bad Relationship? 111
Exercise for counteracting post-acute COVID-19 syndrome in patients with cancer: an old but gold strategy? 106
Exercise and anemia in cancer patients: could make the difference? 104
Impact of exercise in patients with pancreatic cancer across different treatment phases: a systematic review 99
Effect of exercise on functional capacity in patients with advanced cancer: A meta-analysis of randomized controlled trials 98
Exercise oncology: It is time to make a change 97
A qualitative study exploring the experiences and perspectives of patients with cancer attending a 12-week exercise program 96
Molecular predictors of EGFR-mutant NSCLC transformation into LCNEC after frontline osimertinib: digging under the surface 95
A cross-sectional study exploring the perception of exercise oncology in the Italian population 92
Antibody-drug conjugates (ADCs) targeting TROP-2 in lung cancer 92
Plasmacytoid Dendritic Cell, Slan+-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients 90
Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications 89
Genetic and non-genetic resistance mechanisms in non-small cell lung cancer harboring (non-ALK) oncogenic fusions 89
Feasibility of a novel exercise program for patients with breast cancer offering different modalities and based on patient preference 85
Nurses' perspectives on physical activity promotion in cancer patients: A qualitative research 85
Prognostic impact of Interleukin-8 levels in lung cancer: A meta-analysis and a bioinformatic validation 84
Efficacy and safety of afatinib for non-small-cell lung cancer: state-of-the-art and future perspectives 84
Implementation outcomes of early nutritional screening and referral for patients with thoracic cancers 81
Exploring the feasibility of a combined exercise program for patients with advanced lung or pancreatic cancer 77
Integrating nutrition, physical exercise, psychosocial support and antiemetic drugs into CINV management: The road to success 76
Activity of osimeRTInib in non-small-cell lung Cancer with UNcommon epidermal growth factor receptor mutations: retrospective Observational multicenter study (ARTICUNO) 75
ARID1A mutational status in non-small cell lung cancer: from molecular pathology to clinical implications with a focus on the relationships with EGFR 74
Exercise in men with prostate cancer: how to move on? 73
Exercise and bone health in cancer: enemy or ally? 73
Adjuvant Targeted Therapy in Solid Cancers: Pioneers and New Glories 71
Cross-sectional survey evaluating the psychological impact of the COVID-19 vaccination campaign in patients with cancer: The VACCINATE study 70
Study Design and Rationale for Espera Trial: A Multicentre, Randomized, Phase II Clinical Trial Evaluating the Potential Efficacy of Adding SBRT to Pembrolizumab-Pemetrexed Maintenance in Responsive or Stable Advanced Non-Squamous NSCLC After Chemo-Immunotherapy Induction 70
Drive the oncologists into exercise promotion in lung cancer 68
Effect of exercise across the head and neck cancer continuum: a systematic review of randomized controlled trials 67
Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective 67
Willingness, preferences, barriers, and facilitators of a multimodal supportive care intervention including exercise, nutritional and psychological approach in patients with cancer: a cross-sectional study 67
Exploring the role of respiratory microbiome in lung cancer: A systematic review 66
Body composition as a modulator of response to immunotherapy in lung cancer: time to deal with it 66
HER2 Aberrations in NSCLC: So Close Yet So Far 66
Selpercatinib in RET-fusion positive metastatic non-small cell lung cancer: achievements and gray areas 66
The Renaissance of KRAS Targeting in Advanced Non-Small-Cell Lung Cancer: New Opportunities Following Old Failures 66
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC 65
Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy 64
SCLC Treatment in the Immuno-Oncology Era: Current Evidence and Unmet Needs 63
Identification of Targetable Liabilities in the Dynamic Metabolic Profile of EGFR-Mutant Lung Adenocarcinoma: Thinking beyond Genomics for Overcoming EGFR TKI Resistance 62
The frontier of neoadjuvant therapy in non-small cell lung cancer beyond PD-(L)1 agents 61
Patients with NSCLC may display a low ratio of p.T790M vs. activating EGFR mutations in plasma at disease progression: implications for personalised treatment 61
Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study 59
What is the role of physical exercise in the era of cancer prehabilitation? A systematic review 58
Combining a 9-month tailored physical exercise program with osimertinib and denosumab in a patient affected by advanced NSCLC with multiple osteolytic bone lesions: A case report 58
Exceptional Response in BRAF p.V600E-Mutant Enteric-Type Adenocarcinoma of the Lung With Cutaneous Spread: A Case Report 58
Body composition derangements in lung cancer patients treated with first-line pembrolizumab: A multicentre observational study 57
Exploring the Association between Health-Related Physical Fitness and Quality of Life in Patients with Cancer: A Cross-Sectional Study 54
Modern Challenges for Early-Phase Clinical Trial Design and Biomarker Discovery in Metastatic Non-Small-Cell Lung Cancer 54
Deep learning for predicting immunotherapeutic efficacy in advanced non-small cell lung cancer patients: a retrospective study combining progression-free survival risk and overall survival risk 53
Meta-analysis of the prognostic impact of TP53 co-mutations in EGFR-mutant advanced non-small-cell lung cancer treated with tyrosine kinase inhibitors 52
Overcome the Fear of Exercise in Patients With Bone Metastases: A Qualitative Study on Patients' Perception 52
Cardiac autonomic dysfunction in patients with cancer: exploring the role of physical exercise 49
Epidermal growth factor receptor exon 20 insertion variants in non-small cell lung cancer patients 47
Physical Exercise During Neoadjuvant Treatments for Non-Small Cell Lung Cancer: The Time is Coming 47
Unlocking New Horizons in Small-Cell Lung Cancer Treatment: The Onset of Antibody–Drug Conjugates 44
Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed 43
Low fT3/fT4 ratio as a proxy for muscle wasting in patients with advanced non-small cell lung cancer treated with pembrolizumab 39
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 38
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study 38
Physical activity guidelines in oncology: a systematic review of the current recommendations 37
Prognostic and predictive implications of tumor suppressor gene alterations in non-small cell lung cancer 36
Immune Checkpoint Inhibitors and Radiotherapy in NSCLC Patients: Not Just a Fluke 33
Meta-Analysis Exploring Tyrosine Kinase Inhibitor-Induced Weight Gain in Oncogene-Addicted NSCLC 30
Immune Checkpoint Inhibitor Nivolumab and Radiotherapy in Pretreated Lung Cancer Patients: Efficacy and Safety of Combination 29
Lung Cancer Screening: An Opportunity to Promote Physical Activity? 27
From supportive care to adjunctive treatment: the evolution in time of physical exercise and nutrition in lung cancer 27
EGFR and AKT1 overexpression are mutually exclusive and associated with a poor survival in resected gastric adenocarcinomas 25
Effect of exercise on bone-related outcomes in patients with cancer affected by bone metastases or bone loss: a systematic review and meta-analysis 24
How a physical exercise program performed by patients may impact caregiver burden in cancer: a qualitative study 15
Totale 6.362
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.536
article - articoli 27.049
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 487
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.072
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202155 0 0 0 0 2 4 4 8 12 16 9 0
2021/2022180 7 23 0 9 7 10 7 16 12 6 20 63
2022/2023463 22 50 40 93 26 111 1 25 49 12 25 9
2023/2024630 14 25 59 55 57 76 62 36 36 64 91 55
2024/20252.178 99 78 89 367 65 103 147 124 337 162 213 394
2025/20262.839 337 362 612 1.139 389 0 0 0 0 0 0 0
Totale 6.362